Clinical Trials
4 trialsNCT03334305 2026-04-23
ACTION
University of Florida
Phase 1 Terminated
NCT04238819 2026-03-02
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Phase 1/2 Completed
NCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
NCT03615404 2021-01-28
ATTAC-P
Duke University
Phase 1 Completed